NCLEX-style practice question
A client with osteoporosis caused by long-term glucocorticoid therapy is prescribed calcitonin. Which mechanism best explains how this medication reduces blood calcium release from bone?
- Stimulates osteoblasts to deposit calcium into bone matrix
- Inhibits the activity of osteoclasts that break down bone matrix
- Increases calcium absorption in the intestines
- Increases calcium reabsorption in the kidney tubules
Show answer and rationale
Correct answer: B. Inhibits the activity of osteoclasts that break down bone matrix
Calcitonin reduces blood calcium by inhibiting osteoclasts, the bone cells that break down bone matrix and release calcium into the circulation. Increasing renal calcium reabsorption is a PTH action, which raises blood calcium, so it is the opposite of what calcitonin does. Stimulating osteoblasts is also incorrect because osteoblasts build bone rather than release calcium.
Adapted from Open RN Nursing Pharmacology, Chippewa Valley Technical College, CC BY 4.0.
Category: Pharmacological and Parenteral Therapies / Pharmacological Therapies